In a recent statement from PhRMA, Pharmaceutical Research and Manufacturers of America, president and CEO, Stephen Ubl addressed the industry's commitment to ensuring the highest standards of research, clinical testing, and manufacturing are upheld throughout COVID-19 vaccine research and development. Our industry has responded rapidly to a pandemic and this timely fireside chat sets the stage for a week of engaging and enlightening topics. Join our executive director, Sonia Robinson and vice president and chief of medical affairs at PhRMA, Dr. Mike Ybarra with an in depth discussion on the topic that has consumed mainstream media and our daily conversations - COVID-19 vaccines and therapeutics - as well as how our industry was equipped to respond.
You are invited to a Zoom webinar.
When: Oct 5, 2020 09:00 AM Central Time (US and Canada)
Topic: Welcome + Warp Speed Webinar
Please click the link below to join the webinar:
https://us02web.zoom.us/j/83279266380
Or iPhone one-tap :
US: +13017158592,,83279266380# or +13126266799,,83279266380#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 301 715 8592 or +1 312 626 6799 or +1 929 205 6099 or +1 253 215 8782 or +1 346 248 7799 or +1 669 900 6833
Webinar ID: 832 7926 6380
International numbers available: https://us02web.zoom.us/u/kboRSkkUP
In a recent statement from PhRMA, Pharmaceutical Research and Manufacturers of America, president and CEO, Stephen Ubl addressed the industry's commitment to ensuring the highest standards of research, clinical testing, and manufacturing are upheld throughout COVID-19 vaccine research and development. Our industry has responded rapidly to a pandemic and this timely fireside chat sets the stage for a week of engaging and enlightening topics. Join our executive director, Sonia Robinson and vice president and chief of medical affairs at PhRMA, Dr. Mike Ybarra with an in depth discussion on the topic that has consumed mainstream media and our daily conversations - COVID-19 vaccines and therapeutics - as well as how our industry was equipped to respond.